会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明授权
    • Dietary supplements containing extracts of Nelumbo and processes of using same
    • 含有Nelumbo提取物的膳食补充剂及其使用方法
    • US08613959B2
    • 2013-12-24
    • US12702753
    • 2010-02-09
    • Tim RomeroPeter MillerBolin Qin
    • Tim RomeroPeter MillerBolin Qin
    • A61K36/00
    • A61K36/185A61K31/155A61K36/62
    • Materials derived from Nelumbo are administered orally to humans or animals for the purpose of enhancing creatine transport into skeletal tissue and for purposes of enhancing lean body mass. Enhancing creatine transport through improved insulin signaling is a new method of depositing creatine and enhancing lean body mass. Such administration is also used for enhancing athletic performance and controlling bodyweight and body fat levels. More specifically, such administration is used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material is administered as extracts of Nelumbo and administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.
    • 来自Nelumbo的材料经口施用于人或动物,目的是增强肌酸转运到骨骼组织中并用于增强瘦体重的目的。 通过改善胰岛素信号增强肌酸运输是沉积肌酸和增强瘦体重的新方法。 这种管理也用于增强运动表现和控制体重和体脂肪水平。 更具体地,这种施用用于增强肌酸转运到可兴奋组织如骨骼肌中的目的。 该物质作为Nelumbo的提取物施用,并以各种方式施用,包括胶囊,片剂,粉末饮料,酒吧,凝胶或饮料。
    • 34. 发明授权
    • Apparatus for quality control analysis of an on-site prepared pharmaceutical product
    • 用于现场制备的药物产品的质量控制分析的装置
    • US07803320B2
    • 2010-09-28
    • US11747769
    • 2007-05-11
    • Peter MillerAndrew M. LeachEric TelfeyanDavid B. Whitt
    • Peter MillerAndrew M. LeachEric TelfeyanDavid B. Whitt
    • G01N21/00G01N31/00
    • G01N13/00G01N35/00663G01N35/00712G01N2013/006
    • A quality control system for measuring parameters in a pharmaceutical product includes a receiver vessel to receive a pharmaceutical product therein. The quality control system also includes a sample tube having a first end attached to the receiver vessel to remove pharmaceutical product from the receiver vessel and an appendage connected to a second end of the sample tube. The appendage includes at least one chamber therein to receive a quantity of pharmaceutical product from the receiver vessel. A valve positioned within the sample tube controls flow of the pharmaceutical product to the appendage and prevents flow of the pharmaceutical product from the appendage back into the receiver vessel. The system also includes a quality control device configured to measure at least one parameter of the pharmaceutical product in at least one of the receiver vessel and the appendage.
    • 用于测量药物产品中的参数的质量控制系统包括用于在其中接收药物产品的接收器容器。 质量控制系统还包括样品管,其具有附接到接收器容器的第一端以从接收器容器中除去药物产品,以及连接到样品管的第二端的附件。 附件包括至少一个室,以从接收器容器接收一定数量的药品。 定位在样品管内的阀将药物产品的流动控制到附件,并防止药物从附属物流向接收容器。 该系统还包括质量控制装置,该质量控制装置被配置成在接收器容器和附件中的至少一个中测量药品的至少一个参数。